Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
FOCUS
|
PRO
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
-
-
-
-
-
-
Ariad's Wonder Drug For Leukemia PatientsPeter Geschek • Mon, Dec 17, 2012
-
Ariad Passes Its 12-Month Check-UpEP Vantage • Mon, Dec 10, 2012 -
-
-
-
-
-
Ariad's mTOR And The FDA CommitteeProhost Biotech • Wed, Mar 21, 2012
-
-
-
-
-
To learn more about Seeking Alpha Pro, click here.
-
ARIAD Pharmaceuticals CEO Discusses Q3 2010 - Earnings Call TranscriptWed, Nov 10, 2010
-
ARIAD Pharmaceuticals, Inc. Q2 2010 Earnings Call TranscriptWed, Aug 4, 2010
-
ARIAD Pharmaceuticals, Inc. Q1 2010 Earnings Call TranscriptMon, May 10, 2010
-
ARIAD Pharmaceuticals Inc. Q4 2008 Earnings Call TranscriptThu, Feb 12, 2009
-
ARIAD Pharmaceuticals, Inc. Q3 2008 Earnings Call TranscriptThu, Nov 6, 2008
-
ARIAD Pharmaceuticals, Inc. Q2 2008 Earnings Call TranscriptTue, Sep 2, 2008
-
Ariad Pharmaceuticals Inc. Q1 2008 Earnings Call TranscriptMon, May 26, 2008
-
Business Wire (Tue, 2:14PM)
-
Business Wire (Thu, 7:35AM)
-
Business Wire (Jun 11, 2013)
-
Business Wire (Jun 4, 2013)
-
Business Wire (Jun 2, 2013)
-
Business Wire (Jun 2, 2013)
-
Business Wire (May 30, 2013)
-
Business Wire (May 23, 2013)
-
Business Wire (May 15, 2013)
-
Business Wire (May 13, 2013)
-
Business Wire (May 7, 2013)
-
Business Wire (May 6, 2013)
-
Business Wire (Apr 23, 2013)
-
Business Wire (Apr 10, 2013)
-
Business Wire (Apr 4, 2013)
-
Business Wire (Apr 3, 2013)
ARIA vs. ETF Alternatives
Company Description
ARIAD’s vision is to transform the lives of cancer patients with breakthrough medicines. Our mission is to discover, develop and commercialize small-molecule drugs to treat cancer in patients with the greatest and most urgent unmet medical need – aggressive cancers where current therapies are... More
